Equities
  • Price (EUR)366.10
  • Today's Change-1.20 / -0.33%
  • Shares traded40.00
  • 1 Year change+39.10%
  • Beta--
Data delayed at least 15 minutes, as of Nov 20 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Stryker Corporation (Stryker) is a medical technology company. It offers products and services in Medical and Surgical, Neurotechnology, Orthopedics and Spine that help improve patient and healthcare outcomes. It operates through two segments: MedSurg and Neurotechnology, and Orthopedics and Spine. Its products include surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling, emergency medical equipment and intensive care disposable products; clinical communication and workflow solutions; neurosurgical and neurovascular devices; implants used in joint replacement and trauma surgeries; Mako Robotic-Arm Assisted technology; spinal devices; as well as other products. It also develops neurointerventional devices for the treatment of intracranial aneurysms. It offers Fortress, a modular wall system for hospitals and ambulatory surgery centers. It specializes in soft tissue fixation products and delivering AI-assisted virtual care workflows.

  • Revenue in USD (TTM)21.97bn
  • Net income in USD3.59bn
  • Incorporated1946
  • Employees52.00k
  • Location
    Stryker Corp1941 STRYKER WAYPORTAGE 49002United StatesUSA
  • Phone+1 (269) 385-2600
  • Fax+1 (269) 385-1062
  • Websitehttps://www.stryker.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
SYK:NYQ since
announced
Transaction
value
NICO CorpDeal completed20 Sep 202420 Sep 2024Deal completed6.87%--
Vertos Medical IncAnnounced22 Aug 202422 Aug 2024Announced12.98%--
care.ai IncDeal completed12 Aug 202412 Aug 2024Deal completed19.01%--
MOLLI Surgical IncDeal completed31 Jul 202431 Jul 2024Deal completed18.15%--
Artelon IncDeal completed03 Jun 202403 Jun 2024Deal completed14.38%--
Data delayed at least 15 minutes, as of Nov 21 2024 21:10 GMT.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.